| Type | 14-week BTF | 27-week BTF | 39-week BTF | 51-week BTF |
| Maturity | Feb 18, 2026 | May 20, 2026 | Aug 12, 2026 | Nov 4, 2026 |
| Amount | E3.2bln | E1.8bln | E700mln | E1.797bln |
| Target | E2.8-3.2bln | E1.4-1.8bln | E0.3-0.7bln | E1.4-1.8bln |
| Previous | E3.2bln | E497mln | E600mln | E2.1bln |
| Avg yield | 2.030% | 2.044% | 2.047% | 2.065% |
| Previous | 2.010% | 2.029% | 3.564% | 2.059% |
| Bid-to-cover | 2.46x | 4.06x | 3.94x | 3.32x |
| Previous | 3.23x | 5.51x | 5.61x | 3.15x |
| Previous date | Nov 03, 2025 | Nov 03, 2025 | Apr 29, 2024 | Nov 03, 2025 |
Find more articles and bullets on these widgets:
US President Donald Trump is shortly due to deliver an announcement in the White House Oval Office. LIVESTREAM The announcement is expected to relate to drug pricing and could follow a similar template to a recent pledge from Pfizer.
No ratings actions for Belgium from Moody's, which is quoted in a press release on Bloomberg: "Moody's Ratings (Moody's) has completed a periodic review of the ratings of Belgium and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 2 October 2025 in which we reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), and recent developments. This publication does not announce a credit rating action and is not an indication of whether or not a credit rating action is likely in the near future."
Below is the week’s data schedule, with MNI’s annotation of whether or not data will be postponed.
